deltatrials
Completed PHASE3 NCT00003652

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

Intensification Therapy for Locally Advanced Epidermoid Cancer of the Anal Canal - Phase III Intergroup Study

Sponsor: UNICANCER

Conditions Anal Cancer
Interventions cisplatin fluorouracil neoadjuvant therapy radiation therapy
Updated 7 times since 2017 Last updated: Feb 15, 2021 Started: Jan 4, 1999 Primary completion: Apr 1, 2006 Completion: Mar 31, 2007

A PHASE3 clinical study on Anal Cancer, this trial is completed. The trial is conducted by UNICANCER and has accumulated 7 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Mar 2021 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Unknown Status → Completed

  5. Jan 2021 — Mar 2021 [monthly]

    Unknown Status PHASE3

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Jan 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • UNICANCER
Data source: UNICANCER

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Angers, France, Avignon, France, Bordeaux, France, Boulogne-Billancourt, France, Bourg-en-Bresse, France, Caen, France, Chalon-sur-Saône, France, Colmar, France, Créteil, France, Dijon, France and 29 more location s